
    
      To confirm the low-density lipoprotein cholesterol (LDL-C)-lowering effect of 24 weeks of
      treatment with LipitorÂ®(Generic Name : atorvastatin calcium) Tablets and determine the rate
      of achievement of the category-specific target LDL-C level in patients with
      hypercholesterolemia; and to confirm the usefulness (efficacy and safety) of atorvastatin in
      patients who have not responded sufficiently to other statin therapies
    
  